Showing results (181-190 of 582) with videos related to
Sort By:
Pageof 59
European Journal of Medicinal Chemistry|December 1, 2022
Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71Martina Salerno, Carmine Varricchio, Federica Bevilacqua, et al.European Journal of Medicinal Chemistry|March 8, 2014
Synthesis, biological activity and structure-activity relationship of 4,5-dimethoxybenzene derivatives inhibitor of rhinovirus 14 infectionManon Roche, Céline Lacroix, Omar Khoumeri, et al.Mbio|April 9, 2020
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing AntibodiesNiraj Mishra, Robbert Boudewijns, Michael Alexander Schmid, et al.Nature Communications|April 14, 2023
Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatmentRana Abdelnabi, Dirk Jochmans, Kim Donckers, et al.Journal of Medicinal Chemistry|March 8, 2011
Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virusJih Ru Hwu, Shu-Yu Lin, Shwu-Chen Tsay, et al.Journal of Virological Methods|February 5, 2003
A rapid and convenient variant of fusion-PCR to construct chimeric flavivirusesNathalie Charlier, Richard Molenkamp, Pieter Leyssen, et al.Journal of Neurovirology|February 15, 2003
Impact of direct virus-induced neuronal dysfunction and immunological damage on the progression of flavivirus (Modoc) encephalitis in a murine modelPieter Leyssen, Jan Paeshuyse, Nathalie Charlier, et al.Biochemical Pharmacology|September 25, 2016
Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanismRana Abdelnabi, Daryl Staveness, Katherine E Near, et al.Bioorganic & Medicinal Chemistry|March 8, 2020
Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 proteinSalvatore Ferla, Roberto Manganaro, Sara Benato, et al.Microorganisms|March 26, 2022
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster ModelCaroline S Foo, Rana Abdelnabi, Laura Vangeel, et al.Pageof 59